The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVan Elle Regulatory News (VANL)

Share Price Information for Van Elle (VANL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.00
Ask: 34.00
Change: -0.50 (-1.49%)
Spread: 2.00 (6.25%)
Open: 33.50
High: 33.50
Low: 33.00
Prev. Close: 33.50
VANL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

16 Dec 2019 07:00

RNS Number : 9054W
Van Elle Holdings PLC
16 December 2019
 

16 December 2019

Van Elle Holdings plc

("Van Elle" or the "Group")

 

 Trading Update

 

 

 

Van Elle, the UK's largest ground engineering contractor, is issuing the following trading update ahead of the announcement of its results for the six months to 31 October 2019 ("H12020").

 

As set out in Van Elle's full-year results, announced on 24 July 2019, market conditions in the early part of the year were challenging, with customer uncertainty and some heightened competitive pressure resulting in a subdued first quarter. Whilst market conditions have not yet notably improved, the Group's ongoing focus on the initiatives in its transition plan resulted in a stronger second quarter performance.

 

As a result, the Group expects, subject to completion of the interim audit review, to report first half revenues of circa £48m (H12019; £42.9m) and adjusted PBT of circa £1.0m (H12019; £2.8m), reflecting both work mix and the adverse impact of the quiet first quarter. Net debt at 31 October 2019 was £6.4m (H12019; £5.7m) excluding adjustment for leases under IFRS16.

 

Notwithstanding continued short term uncertainty in several of the Group's markets, including the commercial building sector and subdued activity levels in year one of Network Rail's Control Period 6, the Board anticipates modest market improvement during the second half and believes the diversity of the Group's operations and continued delivery of its transition plan initiatives will allow it to maintain the current momentum. Consequently, the Board believes that the Group is on-track to deliver a result for the current year within the range of market expectations.

 

The results for H12020 will be published on 22 January 2020.

 

 

Enquiries:

 

Instinctif Partners (Financial Public Relations) Tel: 020 7457 2020

Mark Garraway

James Gray

Rosie Driscoll

 

Peel Hunt LLP (Nominated Adviser and corporate broker) Tel: 020 7418 8900

Mike Bell

Ed Allsopp

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLFFSIFLLELIA
Date   Source Headline
19th Jul 20197:00 amRNSTrading Update
8th May 20197:00 amRNSDirectorate Change
2nd May 20194:34 pmRNSHolding(s) in Company
2nd May 20197:00 amRNSHolding(s) in Company
30th Apr 20197:30 amRNSHolding(s) in Company
26th Apr 20197:00 amRNSFull year trading update
29th Jan 20191:50 pmRNSDirector/PDMR Shareholding
16th Jan 20197:00 amRNSHalf-year Report
10th Dec 20187:00 amRNSHalf Year Trading Update
19th Oct 20181:11 pmRNSDirector/PDMR Shareholding
18th Sep 20184:55 pmRNSResult of AGM
31st Aug 201810:34 amRNSHolding(s) in Company
13th Aug 20181:00 pmRNSDirector/PDMR Shareholding
26th Jul 20184:43 pmRNSDividend record date
25th Jul 20187:00 amRNSFinal Results
18th May 20187:00 amRNSDirector/PDMR Shareholding
16th May 20181:09 pmRNSDirector/PDMR Shareholding
3rd May 20187:00 amRNSTrading update and CEO succession process
25th Jan 20187:00 amRNSHalf-year Report
19th Jan 20183:07 pmRNSHolding(s) in Company
16th Jan 20189:05 amRNSSecond Price Monitoring Extn
16th Jan 20189:00 amRNSPrice Monitoring Extension
16th Jan 20187:00 amRNSStatement re: Carillion plc
8th Jan 20183:11 pmRNSHolding(s) in Company
15th Dec 20174:54 pmRNSResults of General Meeting
5th Dec 20177:00 amRNSBoard response to the Ellis statement
29th Nov 20177:00 amRNSPosting of Circular to Shareholders
22nd Nov 20177:02 amRNSNotice of GM
22nd Nov 20177:01 amRNSDirectorate Change
22nd Nov 20177:00 amRNSTrading Update
13th Nov 20177:00 amRNSRequisition of General Meeting
1st Nov 20177:00 amRNSAppointment of Non-Executive Director
12th Sep 20173:12 pmRNSResult of AGM
12th Sep 20177:00 amRNSAGM Trading Update
21st Aug 20174:20 pmRNSNotice of AGM
26th Jul 20177:00 amRNSFinal Results
6th Jun 20177:00 amRNSHolding(s) in Company
25th May 20177:00 amRNSTrading Update
5th May 20177:00 amRNSDirector/PDMR Shareholding
27th Apr 20177:00 amRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSDirector/PDMR Shareholding
23rd Mar 20175:27 pmRNSHolding(s) in Company
22nd Mar 20177:00 amRNSTrading Update
6th Mar 20177:00 amRNSDirectorate Change
19th Jan 20177:00 amRNSHalf-year Report
23rd Dec 20167:00 amRNSBoard Change
8th Dec 20167:00 amRNSTrading Update
26th Oct 20167:00 amRNSAdmission and First Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.